Filtered By:
Cancer: Breast Cancer
This page shows you your search results in order of relevance. This is page number 8.
Order by Relevance | Date
Total 82776 results found since Jan 2013.
A long-term retrospective observational study at a medium-sized medical oncology service in Switzerland: comparison of overall survival with a national cohort and adherence to treatment guidelines
CONCLUSIONS: The statistically comparable local 1- and 5-year overall survival of the analysed malignancies, with adjustment for stage for the 5-year overall survival for breast cancer, is in line with the national benchmark. Adherence to treatment guidelines is high.PMID:37459836 | DOI:10.57187/smw.2023.40091
Source: Swiss Medical Weekly - July 17, 2023 Category: General Medicine Authors: Mirjam Gross-Erne Lukas Zimmerli Stefano Bassetti Qiyu Li Anita Feller Walter Mingrone Source Type: research
Global informetric perspective studies on translational medical research
Conclusions:
The subject categories of "Research & Experimental Medicine", "Medical Laboratory Technology", and "General & Internal Medicine" play a key role in translational medical research both in production and in its networks. Translational medical research and CTS, etc. are core journals of translational research. G7 countries are the leading nations for translational medical research. Some developing countries, such as P.R China, also play an important role in the communication of translational research. The USA and its institutions play a dominant role in the production, collaboration, citations and high quality ar...
Source: BMC Medical Informatics and Decision Making - Latest articles - July 26, 2013 Category: Information Technology Authors: Qiang YaoPeng-Hui LyuFei-Cheng MaLan YaoShi-Jing Zhang Source Type: research
Neoadjuvant therapy for early human epidermal growth factor receptor 2 positive breast cancer in China: A multicenter real-world study (CSBrS-015)
Chin Med J (Engl). 2022 Oct 5;135(19):2311-2318. doi: 10.1097/CM9.0000000000002197.NO ABSTRACTPMID:36535009 | DOI:10.1097/CM9.0000000000002197
Source: Chinese Medical Journal - December 19, 2022 Category: General Medicine Authors: Yuanjia Cheng Hongyu Xiang Ling Xin Xuening Duan Yinhua Liu Chinese Society of Breast Surgery (CSBrS), Chinese Society of Surgery of Chinese Medical Association Source Type: research
The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes
Conclusion
These patients may not benefit from screening while also being distressed by receiving an invitation. This issue also makes accurate monitoring and target-setting for improving uptake difficult. Further work is needed to estimate robustly the extent to which medical reasons account for screening non-participation in a larger population.
Source: Journal of Medical Screening - May 12, 2015 Category: Epidemiology Authors: Mead, L., Porteous, L., Tait, M., Stoker, R., Payne, S., Calvert, C., Maxwell, D., Katikireddi, S. Tags: Short Communications Source Type: research
Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis.
CONCLUSIONS: This retrospective claims database analysis of commercially-insured patients with HR+/HER2- mBC in the US showed that everolimus was associated with substantial all-cause, BC-related, and AE-related medical cost savings and less utilization of healthcare resources relative to chemotherapy.
PMID: 27032967 [PubMed - in process]
Source: Journal of Medical Economics - April 3, 2016 Category: Health Management Tags: J Med Econ Source Type: research
FDA adds new clearance for Cianna Medical ’ s Savi Scout breast cancer locator
Cianna Medical said today it won additional FDA 510(k) clearance for its Savi Scout radar localization breast cancer device, now cleared to be placed at the lumpectomy site up to 30 days prior to surgical removal.
Aliso Viejo, Calif.-based Cianna’s Savi Scout is designed to produce audible and visual indicators surgeons can use to tag cancerous tissue during lumpectomy and biopsy procedures.
The surgeon uses a hand piece that emits infrared light and electromagnetic waves to locate a reflector placed in target tissue as long as a week before surgery. After reaching the surgical bulls-eye, the surgeon takes out the target...
Source: Mass Device - August 17, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Oncology Regulatory/Compliance Cianna Medical Source Type: news
Dune Medical lands $3.4m EU grant
Dune Medical Devices said today it won a $3.4 million (EU €3 million) European Union Horizon 2020 research grant.
The company said it is 1 of 65 companies selected to receive funding from the $91 billion (EU €80 billion) 7-year program aiming to “secure Europe’s global competitiveness.”
“This 3 million euro grant will expedite bringing our soft tissue biopsy system to the market. It will provide radiologists and surgeons immediate graphic characterizations of tissue abnormalities along the tip of the biopsy needle, just before samples are taken. This real-time insight can help reduce the time t...
Source: Mass Device - August 23, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Diagnostics Oncology Dune Medical Devices Inc. Source Type: news
